Clinical Trial Update: A Study to Test the Benefit of a New Anti-cancer Treatment in Patients With Unresectable Advanced Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a new anti-cancer treatment in unresectable advanced melanoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: GlaxoSmithKline | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2018-09-07